Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 2
1998 1
2001 2
2002 1
2015 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
[Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
Utratová J, Mayer J, Elbl L, Vorlícek J, Prásek J. Utratová J, et al. Vnitr Lek. 1993 Jun;39(6):575-80. Vnitr Lek. 1993. PMID: 8212613 Czech.
A total of nine patients with diabetes type I and II and with claudications due to macro- and microangiopathies of the lower extremities took sulodexide (Vessel Due F) by the i.m. route for a period of 20 days and then as capsules for 90 days. ...
A total of nine patients with diabetes type I and II and with claudications due to macro- and microangiopathies of the lower extremities too …
Sulodexide in the Treatment of Chronic Venous Insufficiency: Results of the All-Russian Multicenter ACVEDUCT Program.
Chupin AV, Katorkin SE, Katelnitsky II, Katelnitskaya OV, Prostov II, Petrikov AS, Koshevoi AP, Lyudkova LF. Chupin AV, et al. Adv Ther. 2020 May;37(5):2071-2082. doi: 10.1007/s12325-020-01270-9. Epub 2020 Feb 28. Adv Ther. 2020. PMID: 32112279 Clinical Trial.
However, therapeutic agents with evidence-based efficacy for the treatment of CVD are limited. Sulodexide (registered as Vessel Due F in Russia) has confirmed therapeutic efficacy in patients with moderately severe or late-stage CVD, but real-world evidence o …
However, therapeutic agents with evidence-based efficacy for the treatment of CVD are limited. Sulodexide (registered as Vessel Du …
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
Skrha J, Perusicová J, Pont'uch P, Oksa A. Skrha J, et al. Diabetes Res Clin Pract. 1997 Oct;38(1):25-31. doi: 10.1016/s0168-8227(97)00076-4. Diabetes Res Clin Pract. 1997. PMID: 9347243 Clinical Trial.
The effect of glycosaminoglycan sulodexide on albuminuria was studied in a group of 53 diabetic patients (26 Type 1 and 27 Type 2) with micro and macroalbuminuria. Sulodexide (Vessel Due F) was administered intramuscularly in one daily dose (600 lipasemic uni …
The effect of glycosaminoglycan sulodexide on albuminuria was studied in a group of 53 diabetic patients (26 Type 1 and 27 Type 2) with micr …
Search of antimicrobial activity of selected non-antibiotic drugs.
Kruszewska H, Zareba T, Tyski S. Kruszewska H, et al. Acta Pol Pharm. 2002 Nov-Dec;59(6):436-9. Acta Pol Pharm. 2002. PMID: 12669766 Free article.
.), rutoside with ascorbic acid (Cerutin 20+200 mg, tabl.), sulodexide (Vessel due F, 250 LSU, caps.), tegaserole (Zelmac 50 mg, tabl.), telmisartan (Pritor 20 mg, tabl.), temosolomide (Temodal 100 mg, caps.), ticlopidine (Ticlid 250 mg, tabl.), tolfenamic ac …
.), rutoside with ascorbic acid (Cerutin 20+200 mg, tabl.), sulodexide (Vessel due F, 250 LSU, caps.), tegaserole (Zelm …
[Sulodexide in treatment of chronic venous insufficiency. Results of the All-Russian multicenter programme ACVEDUCT].
Chupin AV, Katorkin SE, Katel'nitskiĭ II, Katel'nitskaia OV, Prostov II, Petrikov AS, Koshevoĭ AP, Liudkova LF. Chupin AV, et al. Angiol Sosud Khir. 2018;24(1):47-55. Angiol Sosud Khir. 2018. PMID: 29688194 Russian.
At the same time, there are not so many therapeutic agents intended for treatment of CVD and possessing evidence-based efficacy. Sulodexide (registered in Russia as Vessel Due F) is a drug with a confirmed therapeutic effect in patients with a moderately seve …
At the same time, there are not so many therapeutic agents intended for treatment of CVD and possessing evidence-based efficacy. Sulodexide …
[Significance of endothelial protection in treatment of patients with class c6 chronic venous disease and type 2 diabetes mellitus].
Katorkin SE. Katorkin SE. Angiol Sosud Khir. 2015;21(3):99-102, 104-6. Angiol Sosud Khir. 2015. PMID: 26355928 Clinical Trial. Russian.
The authors studied efficacy of using sulodexide (Vessel Due F) in treatment of patients with clinical class C6 chronic venous disease (CVD) and type 2 diabetes mellitus (DM). ...The time to complete epithelialization in Group I and II patients amounted to 49 …
The authors studied efficacy of using sulodexide (Vessel Due F) in treatment of patients with clinical class C6 chronic …
[New aspects of pharmacologic and general prophylactic care of the diabetic foot].
Záhumenský E, Rybka J, Adamíková A. Záhumenský E, et al. Vnitr Lek. 1995 Aug;41(8):531-4. Vnitr Lek. 1995. PMID: 7483335 Czech.
These preparations include e.g. Trental (pentoxiphilline), Prostavasin (prostaglandin E1), Vessel due F (sulodexide). In advanced stages of ischaemic extremities oedema is a very adverse factor. ...
These preparations include e.g. Trental (pentoxiphilline), Prostavasin (prostaglandin E1), Vessel due F (sulodexide). I …
[A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
Zalevskaia AG, Astamirova KhS, Karpova IA, Popova SG. Zalevskaia AG, et al. Ter Arkh. 1998;70(3):71-4. Ter Arkh. 1998. PMID: 9575594 Clinical Trial. Russian.
MATERIALS AND METHODS: 20 diabetics (diabetes mellitus type I and II) received sulodexide (Vessel due F) for 3 weeks. This mixture of low molecular heparin and dermatan sylphate was injected i.m. once a day for 5 days a week with a 2-day interval. ...
MATERIALS AND METHODS: 20 diabetics (diabetes mellitus type I and II) received sulodexide (Vessel due F) for 3 weeks. T …
11 results